SCHEMBL6028433

SCHEMBL6028433

CC1=C(C(=O)O)C(C2CCCC2)C2=C(CC(C)(C)CC2=O)N1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.54
NCOA1 Q15788 1/20 0.54
NCOA3 Q9Y6Q9 1/20 0.54
GSK3A P49840 1/20 0.48
GSK3B P49841 1/20 0.48
ALDH1A1 P00352 8/20 0.45
KDM4E B2RXH2 8/20 0.45
NPSR1 Q6W5P4 3/20 0.45
TSHR P16473 3/20 0.45
HSD17B10 Q99714 3/20 0.45
HPGD P15428 4/20 0.45
CASP1 P29466 2/20 0.45
CASP7 P55210 2/20 0.45
TP53 P04637 1/20 0.44
GAA P10253 4/20 0.44
GLA P06280 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NOTCH1 P46531 5/20 0.44
CCNA2 P20248 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5815739 0.84 TSHR (0.61) HTTNCOA1NCOA3ALDH1A1KDM4E
SCHEMBL6029208 0.83 NPSR1 (0.62) HTTNCOA1NCOA3ALDH1A1KDM4E
SCHEMBL17198741 0.83 ALDH1A1 (0.63) HTTNCOA1NCOA3GSK3AGSK3B
SCHEMBL6027946 0.81 KDM4E (0.56) HTTNCOA1NCOA3GSK3AGSK3B
SCHEMBL6032037 0.79 GSK3A (0.48) HTTNCOA1NCOA3GSK3AGSK3B
SCHEMBL5816033 0.79 KDM4E (0.58) HTTNCOA1NCOA3GSK3AGSK3B
SCHEMBL6027812 0.78 ALDH1A1 (0.64) HTTNCOA1NCOA3GSK3AGSK3B
SCHEMBL6027944 0.77 NPSR1 (0.52) HTTALDH1A1KDM4ENPSR1TSHR
SCHEMBL8654526 0.73 MAPT (0.40) ALDH1A1KDM4ETSHRHSD17B10TP53
SCHEMBL6461742 0.73 ALDH1A1 (0.68) HTTNCOA1NCOA3GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663227-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS Synta Pharmaceuticals Corporation (US) 2006-06-07 EP disclosed
WO-2005025507-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS SYNTA PHAMACEUTICALS CORP. (US) 2005-03-24 WO disclosed